Baillie Gifford - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$967
-68.9%
1,3760.0%0.00%
Q4 2022$3,110
-22.2%
1,3760.0%0.00%
Q3 2022$4,000
-20.0%
1,3760.0%0.00%
Q2 2022$5,000
-28.6%
1,3760.0%0.00%
Q1 2022$7,000
-63.2%
1,3760.0%0.00%
Q4 2021$19,000
-24.0%
1,3760.0%0.00%
Q3 2021$25,000
-3.8%
1,376
-10.8%
0.00%
Q2 2021$26,000
-16.1%
1,5420.0%0.00%
Q1 2021$31,000
+19.2%
1,542
+2.1%
0.00%
Q4 2020$26,0001,5110.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2022
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders